IHAM
PTCT icon

Integral Health Asset Management’s PTC Therapeutics PTCT Stock Holding History

Integral Health Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100,000
Closed -$5.1M – 94
2025
Q1 		$5.1M Buy
+100,000
New +$4.99M 0.54% 51
2023
Q3 		– Sell
-174,000
Closed -$7.08M – 87
2023
Q2 		$7.08M Sell
174,000
-4,000
-2% -$196K 0.88% 44
2023
Q1 		$8.62M Buy
178,000
+78,000
+78% +$3.57M 1.74% 25
2022
Q4 		$3.82M Sell
100,000
-63,000
-39% -$2.62M 0.8% 45
2022
Q3 		$8.18M Buy
163,000
+58,344
+56% +$2.86M 1.59% 23
2022
Q2 		$4.19M Buy
104,656
+62,656
+149% +$2.2M 0.86% 40
2022
Q1 		$1.57M Sell
42,000
-3,000
-7% -$116K 0.41% 58
2021
Q4 		$1.79M Sell
45,000
-52,100
-54% -$1.99M 0.5% 57
2021
Q3 		$3.61M Sell
97,100
-13,000
-12% -$534K 1.04% 39
2021
Q2 		$4.65M Buy
110,100
+10,000
+10% +$428K 1.28% 31
2021
Q1 		$4.74M Buy
100,100
+70,000
+233% +$4.16M 1.35% 29
2020
Q4 		$1.84M Hold
30,100
– – 0.55% 47
2020
Q3 		$1.41M Buy
30,100
+100
+0.3% +$4.92K 0.43% 64
2020
Q2 		$1.52M Buy
+30,000
New +$1.47M 0.46% 56

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Integral Health Asset Management's PTCT Position: Q2 2025 in Review

Integral Health Asset Management sold out of PTC Therapeutics (PTCT) in Q2 2025, closing a stake of 100,000 shares — an estimated $5.1M sold.

Integral Health Asset Management first reported a position in PTCT in Q2 2020 and held it in 14 quarters. The position peaked at $8.62M in Q1 2023. 283 funds tracked by Wall St. Rank hold PTCT as of Q2 2025.

  • Integral Health Asset Management reported no remaining PTC Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Integral Health Asset Management sold 100,000 PTC Therapeutics shares in Q2 2025, an estimated $5.1M.
  • Integral Health Asset Management first reported a position in PTC Therapeutics in Q2 2020 and held it in 14 quarters.
  • Integral Health Asset Management's PTC Therapeutics position peaked at $8.62M in Q1 2023.
  • 283 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2025.

Based on Integral Health Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.